Tower Research Capital LLC (Trc) Annexon, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Annexon, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 24,892 shares of ANNX stock, worth $69,946. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,892
Previous 5,591
345.22%
Holding current value
$69,946
Previous $33,000
284.85%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
98.2MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$20.8 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$19.7 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$17.7 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$15.8 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $134M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...